Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/105860
Title: P.S.A. and prostatic carcinoma
Other Titles: Trends in pathology in Malta : papers presented at the Third Maltese Medical School Conference 30 November - 2 December 1995
Authors: DeGaetano, J.
Ali, S.
Xuereb, J.
Keywords: Prostate-specific antigen
Prostate -- Cancer
Issue Date: 1995
Publisher: Malta : Department of Pathology, University of Malta
Citation: DeGaetano, J., Alis, S. & Xuereb, J.(1995). P.S.A. and prostatic carcinoma. In M. N. Cauchi (Ed.) Trends in pathology in Malta: papers presented at the Third Maltese Medical School Conference 30 November-2 December 1995 (pp. 55-58). Malta : Department of Pathology, University of Malta.
Abstract: Prostatic carcinoma is the most common form of carcinoma in males in the Western world today. It is the second leading cause of cancer deaths in males superseded only by lung carcinoma. The age adjusted incidence for this cancer in the United States is 69/100,000. There is, however, a marked discrepancy between the high prevalence of prostate cancer and a much lower prevalence of clinical disease. In fact, out of every 100 men with a histological diagnosis of carcinoma, only 25 will develop clinical disease.
URI: https://www.um.edu.mt/library/oar/handle/123456789/105860
Appears in Collections:Trends in Pathology in Malta - Papers presented at the Third Maltese Medical School Conference [30 November - 2 December 1995]

Files in This Item:
File Description SizeFormat 
P.S.A. and prostatic carcinoma.pdf152.53 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.